Drugs / Vitamina B12
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07341789 | Dec 2025 → Apr 2026 overdue | vitamin B12 deficiency | Francisco Javier Martínez Noguera | Enrolling by invitation | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2025-02-13 | Marjan Industria e Comercio ltda | Recomendações e orientações sobre a Vitamina B12 com base no método Delphi marjan.com.br ↗ |
| 2021-05-30 | Enfarma S.p.A. | Diete green e Vitamina B12: parola d’ordine? Integrazione! enfarma.it ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitamina B12 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07341789 ↗ |
| Known as | vitamin B12 | “The aim of this study was to determine the effects of a new formulation of vitamin B12, natural orange extract, and their combination on physical and mental performance.” NCT07341789 ↗ |